Sam Chun Dang Pharm. Co., Ltd (KOSDAQ:000250)
227,000
+10,000 (4.61%)
Sep 19, 2025, 3:30 PM KST
Sam Chun Dang Pharm. Market Cap
Sam Chun Dang Pharm. has a market cap or net worth of 5.28 trillion as of September 19, 2025. Its market cap has increased by 57.86% in one year.
Market Cap
5.28T
Enterprise Value
5.31T
Revenue
215.10B
Ranking
n/a
PE Ratio
n/a
Stock Price
227,000.00
Market Cap Chart
Since September 11, 2001, Sam Chun Dang Pharm.'s market cap has increased from 3.32B to 5.28T, an increase of 158,919.52%. That is a compound annual growth rate of 35.89%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Sep 19, 2025 | 5,279.45B | 52.86% |
Dec 30, 2024 | 3,453.73B | 96.33% |
Dec 28, 2023 | 1,759.15B | 82.00% |
Dec 29, 2022 | 966.58B | 1.04% |
Dec 30, 2021 | 956.65B | -47.20% |
Dec 30, 2020 | 1,811.79B | 137.75% |
Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Samsung Biologics | 72.60T |
Celltrion | 37.10T |
ALTEOGEN | 25.28T |
Yuhan | 8,693.59B |
SK Biopharmaceuticals | 8,410.84B |
Peptron | 6,744.58B |
PharmaResearch | 6,431.19B |
ABL Bio | 5,452.05B |